Inventaire - dina vänner och gemenskaper är ditt bästa bibliotek - Inventaire

Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up

publicerad i: British Journal of Haematology

utgivningsår: 2008-03-26

språk: engelska

huvudämne: Dexametason, Doxorubicin, myelom

Refererar artiklar 5

Datum

Titel

Författare

2006-07-20

International uniform response criteria for multiple myeloma

Athanasios Dimopoulos, Giampaolo Merlini, Gareth J Morgan, S. Vincent Rajkumar, Morie A Gertz
2005-04-04

International staging system for multiple myeloma

Hervé Avet-Loiseau, Bart Barlogie, Robert A Kyle, Pieter Sonneveld, Heinz Ludwig
2005-06-01

PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma
2005-06-01

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.

Sagar Lonial, Kenneth C. Anderson, Pieter Sonneveld, Thierry Facon, Paul G. Richardson, Hartmut Goldschmidt, Edward A. Stadtmauer, Donna E Reece, Jesús San Miguel, Dixie-Lee Esseltine, Jean-Luc Harousseau, Jamie D Cavenagh, Joan Bladé, Mario Boccadoro
1998-09-01

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

Artikel - wd:Q46678869

Välkommen till Inventaire

din gemenskap och vänners bibliotek

du är utloggad